Evidence item

The reported 2,243 denominator and 638 ELISA-positive subset are restricted to a pooled hospital-based Indian surveillance network, a defined July 2019–December 2023 period, children aged 3–23 months, and a test-negative case-control analysis. MEASUREMENT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 25488

Source: Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India · locator {} · excerpt hash sha256:5d4dadac590f0a7627dfb3640d7e77b67a327a1c58cc62e727fc14c67c4dca9a

Exact excerpt

The primary endpoint was vaccine effectiveness against moderate and severe rotavirus gastroenteritis in children under two years, using pooled data from two multicenter observational studies across 32 hospitals in seven Indian states from July 2019 to December 2023. A test-negative case-control design estimated adjusted effectiveness. Among 2,243 children aged 3–23 months hospitalized with acute gastroenteritis, 638 were ELISA-positive for rotavirus; the remaining analysis participants were test-negative controls.

Linked claims

Claim	Direction	Relevance	Steps	Counted
f189543b	QUALIFY	DIRECT	0	yes

Audits

None.